NEBULA
PrivateLast Round
Grant
Mar 25, 2025
Total Funding Raised
$2,000
Momentum Score
50 /100
Company Overview
NEBULA is a biotech company that provides a physics-driven, dataset-free generative AI platform to map 3D conformations of drug targets, reveal cryptic pockets, and design novel therapeutics for pharmaceutical and biotech companies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEBULA Comps
Public and private peers based on sector, stage, and business model.
NEBULA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 25, 2025 | ||||
| Grant | Dec 5, 2024 |
NEBULA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ministry of Higher Education and Research | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2025
$140K grant received from Bpifrance.
- Dec 5, 2024
$2K grant received from Bpifrance and Ministry of Higher Education and Research.
NEBULA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NEBULA's valuation, stock price, and market status.